ReviewWorld journal of gastroenterology2015
Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: a review.
Review in World journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Associating liver partition and portal vein ligation for staged hepatectomy in the treatment of colorectal cancer liver metastases.World journal of gastrointestinal surgery · 2021Review
- The use of neoadjuvant lobar radioembolization prior to major hepatic resection for malignancy results in a low rate of post hepatectomy liver failure.Journal of gastrointestinal oncology · 2021Article
- Liver resections for metastasis: surgical outcomes of a single center academic institution.BMC surgery · 2020Article
- Health education helps to relieve postembolization pain during hepatic arterial chemoembolization therapy.Journal of pain research · 2018Article
- Combined Preoperative Portal and Hepatic Vein Embolization (Biembolization) to Improve Liver Regeneration Before Major Liver Resection: A Preliminary Report.World journal of surgery · 2017Article
- Evolution of associating liver partition and portal vein ligation for staged hepatectomy: Simpler, safer and equally effective methods.World journal of gastroenterology · 2017Article
- Dynamic Evaluation of Liver Volume and Function in Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2017Observational
- Neoadjuvant transarterial radiation lobectomy for colorectal hepatic metastases: a small cohort analysis on safety, efficacy, and radiopathologic correlation.Journal of gastrointestinal oncology · 2017Article
- Patient Survival After Simultaneous ALPPS and Colorectal Resection.World journal of surgery · 2017Article
- Rescue ALPPS is efficient and safe after failed portal vein occlusion in patients with colorectal liver metastases.Langenbeck's archives of surgery · 2017Article
- Clinical Considerations of Focal Drug Delivery in Cancer Treatment.Current drug delivery · 2017Review
- An effective cytokine adjuvant vaccine induces autologous T-cell response against colon cancer in an animal model.BMC immunology · 2016Article
- Article
- Associating liver partition and portal vein ligation for staged hepatectomy: From technical evolution to oncological benefit.World journal of gastrointestinal surgery · 2016Review
- Arterial ischemia in the deportalized liver following associating liver partition and portal vein ligation for staged hepatectomy.World journal of hepatology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer is the third most common cancer in the Western world. Approximately half of patients will develop liver metastases, which is the most common cause of death. The only potentially curative treatment is surgical resection. However, many patients retain a to small future liver remnant (FLR) to allow for resection directly. There are therefore strategies to decrease the tumor with neoadjuvant chemotherapy and to increase the FLR. An accepted strategy to increase the FLR is portal vein occlusion (PVO). A concern with this strategy is that a large proportion of patients will never be operated because of progression during the interval between PVO and resection. ALPPS (associating liver partition and portal vein ligation for staged hepatectomy) is a new procedure with a high resection rate. A concern with this approach is the rather high frequency of complications and high mortality, compared to PVO. In this review, it is shown that with ALPPS the resection rate was 97.1% for CRLM and the mortality rate for all diagnoses was 9.6%. The mortality rate was likely lower for patients with CRLM, but some data were lacking in the reports. Due to the novelty of ALPPS, the indications and technique are not yet established but there are arguments for ALPPS in the context of CRLM and a small FLR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.